|
CN107058101B
(zh)
|
2011-10-17 |
2021-06-01 |
麻省理工学院 |
细胞内传递
|
|
EP3033184B1
(en)
|
2013-08-16 |
2021-03-31 |
Massachusetts Institute of Technology |
Selective delivery of material to cells
|
|
JP7523203B2
(ja)
|
2014-10-31 |
2024-07-26 |
マサチューセッツ インスティテュート オブ テクノロジー |
生体分子の免疫細胞への送達
|
|
SG10201912910PA
(en)
|
2015-07-09 |
2020-02-27 |
Massachusetts Inst Technology |
Delivery of materials to anucleate cells
|
|
ES2930017T3
(es)
|
2015-09-04 |
2022-12-05 |
Sqz Biotechnologies Co |
Suministro intracelular de biomoléculas mediado por una superficie con poros
|
|
JP7602702B2
(ja)
|
2016-05-03 |
2024-12-19 |
ステムセル テクノロジーズ カナダ インコーポレーテッド |
寛容性を誘導するための生体分子の細胞内送達
|
|
KR102490952B1
(ko)
|
2016-05-03 |
2023-01-19 |
에스큐지 바이오테크놀로지스 컴퍼니 |
관용을 유도하는 생체분자의 세포내 전달
|
|
EP3765068A2
(en)
|
2018-03-12 |
2021-01-20 |
SQZ Biotechnologies Company |
Intracellular delivery of biomolecules to modify immune response
|
|
US12599656B2
(en)
|
2018-03-12 |
2026-04-14 |
Stemcell Technologies Canada Inc. |
Methods for treating HPV-associated diseases
|
|
KR20210070338A
(ko)
|
2018-10-04 |
2021-06-14 |
에스큐지 바이오테크놀로지스 컴퍼니 |
항원 제시 세포 기능을 증진시키기 위한 생체분자의 세포내 전달
|
|
WO2020154696A1
(en)
|
2019-01-25 |
2020-07-30 |
Sqz Biotechnologies Company |
Anucleate cell-derived vaccines
|
|
CA3131701A1
(en)
|
2019-02-28 |
2020-09-03 |
Sqz Biotechnologies Company |
Delivery of biomolecules to pbmcs to modify an immune response
|
|
CA3150224A1
(en)
*
|
2019-09-10 |
2021-03-18 |
Obsidian Therapeutics, Inc. |
Ca2 compositions and methods for tunable regulation
|
|
AU2020355025A1
(en)
*
|
2019-09-23 |
2022-04-07 |
Regents Of The University Of Minnesota |
Genetically-edited immune cells and methods of therapy
|
|
TW202241508A
(zh)
*
|
2021-01-29 |
2022-11-01 |
美商艾歐凡斯生物治療公司 |
細胞介素相關之腫瘤浸潤性淋巴球組合物及方法
|
|
WO2023010090A1
(en)
*
|
2021-07-29 |
2023-02-02 |
Sqz Biotechnologies Company |
Methods to generate enhanced tumor infiltrating lymphocytes through microfluidic delivery
|